Re-Vana Therapeutics

Re-Vana Therapeutics is a company that develops a biodegradable drug delivery platform. It develops sustained-release ophthalmic therapeutics that can reduce the frequency of intravitreal injections required to treat a wide range of retinal diseases, including neovascular age-related macular degeneration.